Radiant Biotherapeutics
Strength, tunability, and breadth in biologics
Toronto, Canada · Founded 2020 · $145.0M raised
- Headquarters
- Toronto
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- radiantbio.com
- Total Funding
- $145.0M
- Last Round
- $80.0M Series BMar 2023
- Rounds
- 3
About
Radiant Biotherapeutics is a Toronto-based preclinical biotech founded 2020, advancing Multabody therapies harnessing nature's protein scaffolding. Cancer and infectious diseases. Backed by Amplitude Ventures and Gates Foundation. $35M Series A 2024.
Summary
Radiant Biotherapeutics is a Biotech company based in Toronto, Canada, founded in 2020. It has raised $145.0M in total across 3 rounds, most recently a $80.0M Series B round in Mar 2023. Investors include BDC Venture Capital, Aisling Capital and Forerunner Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company